Side Effects and What Needs Monitoring No effective metabolic medicine is free of side effects, and Retatrutide is no exception
Deliberately pushing that pathway harder has a theoretical cancer-risk question attached that has never been studied in humans, because dihexa has never been studied in humans at all
Long-term cardiovascular outcomes look positive: semaglutide reduced the risk of major adverse cardiac events by 26% in patients with existing heart disease or diabetes in the SELECT trial
Cell 59 (19), 25322548
In another study of UC patients, those who developed irAEs had an ORR of 33.0% versus 8%, and at 15 months median follow-up, all the patients with irAEs were still alive, compared to only 38% of their counterparts [63]
Plus, if you're someone who finds full-dose GLP-1s a bit too hardcore, Ill share an alternative that might be a better fit